Tailored versus Triple plus Bismuth or Concomitant Therapy as InitialHelicobacter pyloriTreatment: A Randomized Trial
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tailored versus Triple plus Bismuth or Concomitant Therapy as InitialHelicobacter pyloriTreatment: A Randomized Trial
Authors
Keywords
-
Journal
HELICOBACTER
Volume 21, Issue 2, Pages 91-99
Publisher
Wiley
Online
2015-06-24
DOI
10.1111/hel.12242
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Comparative Study of Sequential Therapy and Standard Triple Therapy for Helicobacter pylori Infection: A Randomized Multicenter Trial
- (2014) Liya Zhou et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Prospective multi-region study on primary antibiotic resistance of Helicobacter pylori strains isolated from Chinese patients
- (2014) Zhiqiang Song et al. DIGESTIVE AND LIVER DISEASE
- Efficacy of tailoredHelicobacter pylorieradication therapy based on antibiotic susceptibility andCYP2C19genotype
- (2014) Mitsushige Sugimoto WORLD JOURNAL OF GASTROENTEROLOGY
- Antimicrobial susceptibility testing forHelicobacter pyloriin times of increasing antibiotic resistance
- (2014) Sinéad M Smith WORLD JOURNAL OF GASTROENTEROLOGY
- Optimizing clarithromycin-containing therapy forHelicobacter pyloriin the era of antibiotic resistance
- (2014) Javier Molina-Infante WORLD JOURNAL OF GASTROENTEROLOGY
- Optimized Nonbismuth Quadruple Therapies Cure Most Patients With Helicobacter pylori Infection in Populations With High Rates of Antibiotic Resistance
- (2013) Javier Molina–Infante et al. GASTROENTEROLOGY
- Randomised clinical trial comparing sequential and concomitant therapies forHelicobacter pylorieradication in routine clinical practice
- (2013) Adrian G McNicholl et al. GUT
- Effect of dosing schemes of amoxicillin on eradication rates ofHelicobacter pyloriwith amoxicillin-based triple therapy
- (2013) Takahisa Furuta et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Fourth Chinese National Consensus Report on the management ofHelicobacter pyloriinfection
- (2013) et al. Journal of Digestive Diseases
- A comparison of the acid-inhibitory effects of esomeprazole and rabeprazole in relation to pharmacokinetics and CYP2C19 polymorphism
- (2012) N. G. Hunfeld et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Rabeprazole 10 mg q.d.s. decreases 24-h intragastric acidity significantly more than rabeprazole 20 mg b.d. or 40 mg o.m., overcoming CYP2C19 genotype
- (2012) M. Sugimoto et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Management ofHelicobacter pyloriinfection—the Maastricht IV/ Florence Consensus Report
- (2012) Peter Malfertheiner et al. GUT
- Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: a multicentre clinical trial
- (2012) J.-M. Liou et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Lansoprazole-based sequential and concomitant therapy for the first-line Helicobacter pylori eradication
- (2012) Yao-Kang HUANG et al. Journal of Digestive Diseases
- The challenge of Helicobacter pylori resistance to antibiotics: the comeback of bismuth-based quadruple therapy
- (2012) Francis Mégraud Therapeutic Advances in Gastroenterology
- Primary Antibiotic Resistance of Helicobacter pylori Isolated from Beijing Children
- (2011) Guodong Liu et al. HELICOBACTER
- World Gastroenterology Organisation Global Guideline: Helicobacter pylori in Developing Countries
- (2011) Journal of Digestive Diseases
- Optimal therapy for Helicobacter pylori infections
- (2011) Emiko Rimbara et al. Nature Reviews Gastroenterology & Hepatology
- Pharmacologic Aspects of Eradication Therapy for Helicobacter pylori Infection
- (2010) Takahisa Furuta et al. GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- Helicobacter pylori treatment in the era of increasing antibiotic resistance
- (2010) D. Y. Graham et al. GUT
- Rabeprazole Can Overcome the Impact of CYP2C19 Polymorphism on Quadruple Therapy
- (2010) Chao-Hung Kuo et al. HELICOBACTER
- Sequential and Concomitant Therapy With Four Drugs Is Equally Effective for Eradication of H pylori Infection
- (2009) Deng–Chyang Wu et al. Clinical Gastroenterology and Hepatology
- Review: Improving compliance with Helicobacter pylori eradication therapy: when and how?
- (2009) John P. Anthony O'Connor et al. Therapeutic Advances in Gastroenterology
- New concepts of resistance in the treatment of Helicobacter pylori infections
- (2008) David Y Graham et al. Nature clinical practice. Gastroenterology & hepatology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now